These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38890811)

  • 1. Use of Lomustine and Prednisolone as First-Line Treatment in Canine Multicentric Lymphoma.
    Catalucci C; Bianchi ML; Treggiari E; Pieri M; Ruess K; Valenti P
    Vet Comp Oncol; 2024 Sep; 22(3):422-428. PubMed ID: 38890811
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
    Morgan E; O'Connell K; Thomson M; Griffin A
    Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
    Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
    Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lomustine and prednisone as a first-line treatment for dogs with multicentric lymphoma: 17 cases (2004-2005).
    Sauerbrey ML; Mullins MN; Bannink EO; Van Dorp TE; Kaneene JB; Obradovich JE
    J Am Vet Med Assoc; 2007 Jun; 230(12):1866-9. PubMed ID: 17571992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Retrospective Study of Multi-agent Chemotherapy including either Cyclophosphamide or Lomustine as Initial Therapy for Canine High-grade T-cell Lymphoma (2011-2017).
    Elliott J; Baines S
    Aust Vet J; 2019 Sep; 97(9):308-315. PubMed ID: 31328256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
    Blaxill J; Buzzacott P; Finlay J
    Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of a 12-week combination chemotherapy followed by lomustine consolidation treatment in canine B- and T-cell lymphoma.
    Limmer S; Nerschbach V; Eberle N; Teske E; Simon Betz D
    Acta Vet Scand; 2022 Dec; 64(1):36. PubMed ID: 36503518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical response and prognostic factors in canine multicentric lymphoma treated with first rescue therapy.
    Blaxill JE; Bennett PF
    Vet Comp Oncol; 2024 Jun; 22(2):265-277. PubMed ID: 38646859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with L-asparaginase, lomustine, and prednisone for relapsed or refractory canine lymphoma.
    Saba CF; Thamm DH; Vail DM
    J Vet Intern Med; 2007; 21(1):127-32. PubMed ID: 17338160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
    Brown PM; Tzannes S; Nguyen S; White J; Langova V
    Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results.
    Zandvliet M; Rutteman GR; Teske E
    Vet J; 2013 Sep; 197(3):656-61. PubMed ID: 23746872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early progression during or after cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy indicates poor outcome with rescue protocols in dogs with multicentric lymphoma.
    Parker AS; Burton JH; Curran KM; Wolf-Ringwall A; Thamm DH
    J Vet Intern Med; 2024; 38(4):2282-2292. PubMed ID: 38961691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination chemotherapy with continuous L-asparaginase, lomustine, and prednisone for relapsed canine lymphoma.
    Saba CF; Hafeman SD; Vail DM; Thamm DH
    J Vet Intern Med; 2009; 23(5):1058-63. PubMed ID: 19678892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Temozolomide alone or in combination with doxorubicin as a rescue agent in 37 cases of canine multicentric lymphoma.
    Treggiari E; Elliott JW; Baines SJ; Blackwood L
    Vet Comp Oncol; 2018 Jun; 16(2):194-201. PubMed ID: 28766920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological characteristics and prognostic factors for canine multicentric non-indolent T-cell lymphoma: 107 cases.
    Purzycka K; Peters LM; Desmas I; Davies O; Chang YM; Lara-Garcia A
    Vet Comp Oncol; 2020 Dec; 18(4):656-663. PubMed ID: 32163214
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison between symptomatic treatment and lomustine supplementation in 71 dogs with intracranial, space-occupying lesions.
    Van Meervenne S; Verhoeven PS; de Vos J; Gielen IM; Polis I; Van Ham LM
    Vet Comp Oncol; 2014 Mar; 12(1):67-77. PubMed ID: 22738696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lomustine (CCNU) for the treatment of resistant lymphoma in dogs.
    Moore AS; London CA; Wood CA; Williams LE; Cotter SM; L'Heureux DA; Frimberger AE
    J Vet Intern Med; 1999; 13(5):395-8. PubMed ID: 10499719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is CCNU (lomustine) valuable for treatment of cutaneous epitheliotropic lymphoma in dogs? A critically appraised topic.
    Laprais A; Olivry T
    BMC Vet Res; 2017 Feb; 13(1):61. PubMed ID: 28222789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective evaluation of lomustine (CeeNU) in 32 treatment naïve cats with intermediate to large cell gastrointestinal lymphoma (2006-2013).
    Rau SE; Burgess KE
    Vet Comp Oncol; 2017 Sep; 15(3):1019-1028. PubMed ID: 27277825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of lomustine as a rescue agent for cats with resistant lymphoma.
    Dutelle AL; Bulman-Fleming JC; Lewis CA; Rosenberg MP
    J Feline Med Surg; 2012 Oct; 14(10):694-700. PubMed ID: 22577051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.